The strongest difference was observed for CDKN2BAS-rs1011970, although it was not statistically significant considering multiple testing (P value for case-case comparison = 0.006), suggesting a stronger association of CDKN2BAS-rs1011970 with BCIS than with invasive BC. Here, CDKN2B-AS1 is linked to breast cancer.